# Federal lab technology licensing: patent licenses and CRADAs explained

URL: https://zernyxhub.com/blog/federal-lab-technology-licensing
Author: Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP
Published: 2026-11-11
Category: Licensing

> Federal lab technology transfer for Indian companies: how US federal patent licenses and CRADAs work, what the law requires, notice periods and foreign rules.

**Short answer:** US federal laboratories transfer technology in two main ways: patent licences under 35 U.S.C. 209 and 37 CFR Part 404, and cooperative research and development agreements (CRADAs) under 15 U.S.C. 3710a. A licence gives rights to an existing invention. A CRADA is joint research where the lab contributes staff, facilities or IP, never funds.

US federal laboratories, from health and energy labs to standards and space agencies, hold thousands of patents and run research that companies can join. An Indian company has two doors in. One is a licence to an invention the government already owns. The other is a CRADA, a joint research agreement that can produce new inventions the company can then license.

The two are governed by different laws and suit different situations. This post explains each, what the law requires, how foreign-owned firms are treated, and how to choose.

## What are the two routes?

| | Patent licence | CRADA |
|---|---|---|
| What you get | Rights to an existing federal invention | Joint research, and rights to resulting inventions |
| Main law | 35 U.S.C. 209; 37 CFR Part 404 | 15 U.S.C. 3710a |
| What the lab contributes | The invention | Staff, services, facilities, equipment or IP; never funds |
| What you contribute | Fees and royalties, and a development plan | Funds or resources for the research |
| Exclusivity | Exclusive, partially exclusive or non-exclusive | Option to choose an exclusive licence in a pre-negotiated field |
| Typical use | Ready technology you want to commercialise | Technology you need to develop with the lab |

Sources: [35 U.S.C. 209](https://www.law.cornell.edu/uscode/text/35/209), [37 CFR Part 404](https://www.ecfr.gov/current/title-37/chapter-IV/part-404) and [15 U.S.C. 3710a](https://www.govinfo.gov/link/uscode/15/3710a).

Agencies run their own programmes under these laws. NIH and NASA each publish licence types and indicative terms; see [how to license a technology from NIH](https://zernyxhub.com/blog/license-technology-from-nih) and [NASA patent licenses](https://zernyxhub.com/blog/nasa-patent-license).

## How does a federal patent licence work?

The application goes to the agency that holds the invention. Under 37 CFR 404.8 it normally includes:

| Item | What to provide |
|---|---|
| The invention | Patent or application number, title, date |
| Licence type | Exclusive, partially exclusive or non-exclusive |
| Applicant | Name, address, citizenship or place of incorporation, contact |
| Business | Nature of business, products, approximate number of employees, small business status |
| Development or marketing plan | Time, capital and resources to reach practical application; capability; fields of use; where it will be made and sold |
| History | Earlier federal licences held |
| Market | Whether industry or government already practise the invention |

Section 209(f) says no licence may be granted without a development or marketing plan, which the agency keeps confidential. Section 209(d) requires every licence to reserve a paid-up licence for the federal government, require periodic reports on use, and allow termination if the licensee does not carry out its plan.

For exclusive and partially exclusive licences, 209(a) adds conditions: the licence must be a reasonable and necessary incentive for investment, serve the public interest, and not substantially lessen competition. Small businesses get first preference under 209(c) if they are equally likely to commercialise. The agency must give public notice at least 15 days before granting such a licence, under 209(e). Non-exclusive licences need no advance notice (37 CFR 404.6).

**Taking a federal patent licence**
1. Find the invention: Agency portfolio or patent search
2. Apply to the agency: With a development plan
3. Negotiate: Type, field, fees, reports
4. Public notice: At least 15 days if exclusive
5. Sign and report: Periodic use reports

## How does a CRADA work?

A CRADA is an agreement between one or more federal labs and non-federal parties to do research consistent with the lab's mission. The lab may contribute personnel, services, facilities, equipment, intellectual property or other resources, with or without reimbursement, but it may not give the partner money. The partner contributes funds or resources.

On inventions, 15 U.S.C. 3710a lets the lab grant the partner a licence, an assignment or an option to inventions made under the CRADA, and requires that the partner can choose an exclusive licence for a pre-negotiated field of use. The government keeps a non-exclusive, irrevocable, paid-up licence to use the invention for government purposes, and in exceptional cases, such as unmet health or safety needs, can require licensing to others.

Information is protected. Trade secrets and confidential commercial information from the partner may not be disclosed, and information developed under the CRADA can be protected from disclosure for up to five years, including under the Freedom of Information Act.

37 CFR 404.8(b) adds a useful link: a signed CRADA that lets the partner use a federal invention for research can be treated as a licence application, if it covers the information a licence application needs.

**Licence or CRADA**
Patent licence:
- Invention already exists
- Fees and royalties
- Development plan required
CRADA:
- Joint research first
- Lab gives staff and facilities, not funds
- Option on new inventions
License what is ready; use a CRADA when the technology still needs the lab.

## What should a foreign-owned company know?

| Rule | Source | Effect |
|---|---|---|
| Preference for US units that manufacture substantially in the US | 15 U.S.C. 3710a | Applies when the lab chooses CRADA partners |
| Reciprocity check for foreign-controlled firms | 15 U.S.C. 3710a | The lab considers whether the firm's home government allows US firms similar agreements |
| Licences to use or sell in the US normally require substantial US manufacture | 35 U.S.C. 209(b); 37 CFR 404.5 | Can be waived under 37 CFR 404.5 if domestic manufacture is not commercially feasible or no domestic licensee was found |

None of these is a bar. They shape the plan. An Indian company that intends to sell in the US should explain where it will manufacture, and whether it will seek a waiver, in the development plan. For selling only outside the US, check where the federal patent family is in force; [search US university technology](https://zernyxhub.com/blog/search-us-university-technology) covers patent searches.

## A worked example

**Illustration with invented figures.** A Pune materials company wants a coating developed at a US federal lab.

| Option | Cost to the company | What it gets |
|---|---|---|
| Non-exclusive licence to the existing patent | $15,000 upfront, 3% royalty on US sales | Rights to the current coating; no notice period |
| Two-year CRADA to adapt the coating for Indian humidity | $120,000 in funds plus its own engineers' time | Lab staff and test facilities; option to an exclusive licence in a pre-negotiated field |

The company picks the CRADA, because the existing coating fails its humidity tests. It negotiates the exclusive field as "coatings for building materials", confirms where the resulting patents will be filed, explains its Indian manufacturing plan, and accepts that the US government keeps its own licence.

Before signing either agreement, ask the lab for a draft early, because federal agreements follow model forms and changes take time to approve.

## Common mistakes

- Applying for a licence when the technology still needs development a CRADA would provide.
- Expecting the lab to fund the joint work.
- A thin development or marketing plan.
- Not agreeing the exclusive field before the CRADA starts.
- Ignoring the US manufacturing rules when US sales are planned.

My view: for most Indian companies, a non-exclusive licence is the quickest first step, and a CRADA makes sense only when the lab's people and equipment add something you cannot buy. I am less certain how often foreign-controlled firms win CRADAs in practice, because labs do not publish partner nationality in a consistent way; ask the lab's technology transfer office early.

For research agreements in India, see [sponsored research agreements](https://zernyxhub.com/blog/sponsored-research-agreement). To compare federal lab technologies with Indian and other sources, [Zernyx Hub](https://www.zernyxhub.com) has mapped patents from universities across India, with AI business insight on each.

## Common questions

### What is a CRADA?

A cooperative research and development agreement between one or more federal laboratories and non-federal parties. The lab may provide personnel, services, facilities, equipment, intellectual property or other resources, with or without reimbursement, but may not provide funds. The partner contributes funds or resources.

### Who owns inventions made under a CRADA?

The CRADA decides. The law lets the lab grant the partner a licence, assignment or option on inventions made under the agreement, and requires that the partner can choose an exclusive licence in a pre-negotiated field. The government keeps a non-exclusive, paid-up licence for government purposes.

### Can an Indian company sign a CRADA or take a federal patent licence?

It can apply. The lab director must prefer US business units that agree to manufacture substantially in the United States, and for foreign-controlled firms must consider whether their government allows US firms similar agreements. Licences to sell in the US normally require substantial US manufacture, which can be waived.

### How long is the notice period for an exclusive federal licence?

Under 35 U.S.C. 209(e), the agency must give public notice at least 15 days before granting an exclusive or partially exclusive licence, and consider comments received. Non-exclusive licences need no advance public notice under 37 CFR 404.6.

---

Published by Zernyx Hub. More: https://zernyxhub.com/llms.txt
